Top Tweets for #ptcy
Dr. Shernan Holtan's @MedNewsWeek keynote explores how post-transplant cyclophosphamide (PTCy) has changed the donor-selection conversation in allogeneic transplantation.
Explore the full discussion: https://t.co/Q7PlcxvVdd
#Hematology #GVHD #PTCy #MedNewsWeek
Only 1 in 5 eligible patients receives transplantation or cellular therapy.
A striking access gap highlighted by Dr. @sghmd. Innovation must go hand in hand with access.
@MedNewsWeek x @oncodaily
https://t.co/4FPLQRBiVH
Interesting real-world data on
PTCy 80 vs 100 mg/kg 👇
80 mg/kg showed
Earlier neutrophil engraftment, while NRM, relapse and OS remained similar.
Maybe less can still be enough.
#PTCy #HaploHSCT #BMT #GVHD

Amazing to see how an idea from the 1980s became the backbone of modern PTCy.
Selective removal of alloreactive T cells — simple concept, huge impact in haplo-HSCT.
#APBMT26
#PTCy #HaploHSCT #BMT #GVHD

Our latest article in @ASTCT_Journal shows that in the #PTCy era, conditioning intensity independently impacts relapse, DFS, and aGVHD, but not OS, NRM, or GRFS after #URD allo-HCT.
@MoffittNews @mumairmushtaq @MediHumdani @kashifaminMD @ASTCT https://t.co/wUC0aTMD1J

Our latest article in @ASTCT_Journal shows Haplo-HCT with #PTCy delivers outcomes comparable to MSD-HCT, supporting its use as a robust alternative when a matched sibling donor is unavailable. @mumairmushtaq @MediHumdani @Abdallah81MD @MoffittNews @ASTCT https://t.co/3MpC4hEJMH

KÖK HÜCRE NAKLİNDE YENİ PARADİGMA: DONÖR YAŞI ARTIK ÇOK ÖNEMLİ
❓ En iyi verici kim?
❓ Özellikle transplant sonrası siklofosfamit (#PTCy) döneminde en önemli kriter ne?
❓ Modern #transplantasyon çağında en kritik belirleyici artık DONÖR YAŞI mı?
👉Kawamura ve arkadaşlarının güncel #Haematologica dergisinde yayımlanan geniş #TRUMP Registry analizinde (17.848 #allojenik transplant hastası), donör seçiminde dikkat çekici bir sonuç ortaya kondu:
➡️ Özellikle ≥50 yaş hastalarda;
✅ Genç #HLA tam uyumlu akraba dışı donör (M-UD-Y),
✅ Yaşlı HLA tam uyumlu kardeş vericiden daha iyi toplam sağkalım (OS) sağlayabildi.
➡️ Bu çalışma, allojenik nakilde klasik
“önce #kardeş donör” yaklaşımının yeniden değerlendirilmesi gerektiğini göstermektedir.
📌 Modern #transplant yaklaşımında artık yalnızca HLA uyumu değil;
✔️ #Donör yaşı
✔️ İmmünolojik kalite
✔️ #CMV uyumu
✔️ Donör cinsiyeti/paritesi
✔️ Klonal hematopoiesis
✔️ Donör fitness’i
✔️ PTCy döneminde haploidentik stratejiler
gibi çok boyutlu biyolojik faktörler önem kazanmaktadır.
🎯 Son Söz:
“En uygun donör, her zaman en yakın akraba olmayabilir;
en genç ve biyolojik olarak en avantajlı donör olabilir.”
➡️ Detay: Kawamura K. et al. Haematologica. 2026;111(5).
https://t.co/qWUJFsugTl
#hematoloji #transplantasyon #kokhucre #kokhucrenakli #donor #losemi #akutlosemi #AML #ALL #MDS #HLA #Haplo
#profdrfevzialtuntas

“I Reunió Transversal de Teràpia Cel·lular ICO 2026” @ICO_oncologia
Felipe Peña-Muñoz @HematoRules @HematICO_Hosp va presentar “Homogeneïtzació profilaxi GVHD”
El futur de la #PTCy dosis i ajustaments per millorar els resultats del trasplantament al·logènic

Our latest article in #CLML explores Allo-HCT with #PTCy in carefully selected patients aged >70 years with AML/MDS & supports individualized transplant referral rather than age-based exclusion in fit older patients. @mumairmushtaq @MoffittNews https://t.co/cGhvZigMS4

Excited to present #haploidentical #SCT with #PTCy➡️Myeloablation:not always the answer 🙅🏽♀️
In an era where donor platforms, #GVHD prophylaxis, and #posttransplant maintenance have fundamentally shifted, clinging to intensity as a default strategy may be holding us back.
#EMBT

Excellent Educational cession:
#PTCyParadox
#CAST PTCy, no MMF (MRD)
#PTCy partners (Rux,ATG,Abatacept)
#Resolved

On #EBMT26 stage, @GETH_info president Dr Montserrat Rovira from @hospitalclinic giving a lecture on #infections in #PTCY setting

Important work from Dr. Megan Herr @RoswellPark using publicly available @CIBMTR data showing that, even in the #PTCy era, survival outcomes vary by race/ethnicity and donor type. More work to be done, and data analysis with more donor/recipient pairs ongoing.

Let's be honest with ourselves. 👀
Caregiver needs, toxicity, support, cost, distance, referral, relapse -- these are the main barriers to curative allogeneic hematopoietic cell transplant, too.
With #PTCy markedly improving safety, most of our attention should be focused on these barriers.
Important lessons here summarized by @CIBMTR: https://t.co/UKAjvw88bg
Enhorabuena a la Dra @QueraltSalas y el resto del equipo @GETH_info Munárriz D et al.
Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in AML.
👉 DOI: 10.3389/fimmu.2025.1700463
#CT #AML #GETHTC #HaploHCT #PTCy
Tell me the one medication that truly impressed you.
Last Seen Hashtags on Sotwe
blackpyt()*+filter:videos(**)*
Seen from United States
舔脚
Seen from United States
معصيتّيَ_رِحّتِي
Seen from Oman
ديوث
Seen from Egypt
hunnyjolee
Seen from United Kingdom
MGAI
Seen from Brazil
MacedoniaNP
Seen from Greece
女骑士
Seen from Netherlands
latincum
Seen from United States
รับงานสาย5
Seen from Thailand
Most Popular Users

Elon Musk 
@elonmusk
240.4M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.7M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.3M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers























